Live Breaking News & Updates on Abbvie Biotherapeutics

Stay updated with breaking news from Abbvie biotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elotuzumab Plus Pomalidomide and Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma

Researchers determined elotuzumab with pomalidomide and dexamethasone improved overall survival in patients with relapsed/refractory multiple myeloma. ....

Abbvie Biotherapeutics , Bristol Myers Squibb ,